In case you missed any, read a recap of the episodes of OncLive On Air that aired in July 2026.
Commentary|Videos|October 10, 2024
Menin Inhibitors for AML: A Roundtable on the Latest Advances
Author(s)Justin Kaner, MD
Justin Kaner, MD, discusses the latest advances surrounding menin inhibitors in acute myeloid leukemia.
Advertisement
Justin Kaner, MD, discusses the latest advances surrounding menin inhibitors in acute myeloid leukemia.
Newsletter
Stay up to date on the most recent and practice-changing oncology data
SubscribeAdvertisement
Related to this article
The FDA approved RP1 plus nivolumab in advanced melanoma, granted olomorasib breakthrough status in KRAS G12C+ pancreatic cancer, and more.
Advertisement
Advertisement
Trending on OncLive
1
Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma
2
ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC
3
FDA Grants Fast Track Designation to PLN-101095 Plus Pembrolizumab in Solid Tumors
4
mRNA Vaccines May Help Increase Long-Term Disease Control in PDAC
5